We are live on ! Find out more
MTNB icon

Matinas BioPharma

61 hedge funds and large institutions have $67.4M invested in Matinas BioPharma in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 7

258% more capital inflows, than outflows

Capital inflows: $6.99M | Capital outflows: $1.96M

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

74% more funds holding

Funds holding: 35 → 61 (+26)

2.08% more ownership

Funds ownership: 16.19% → 18.27% (+2.1%)

Holders
61
Holders Change
+26
Holders Change %
+74.29%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
11
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MTNB Hedge Fund Activity: Q4 2019 in Review

61 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q4 2019, worth a combined $67.4M — up 307% from $16.6M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new MTNB positions and 7 closed out — a net gain of 26 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $1.61M. The largest seller was Granite Point Capital Management, exiting entirely with an estimated $946K sold.

  • 61 institutional investors held Matinas BioPharma (MTNB) as of Q4 2019, up from 35 in Q3 2019.
  • Funds reported $67.4M of Matinas BioPharma stock for Q4 2019, up 307% quarter-over-quarter.
  • 33 funds opened new Matinas BioPharma positions in Q4 2019 and 7 closed out, a net change of +26 holders.
  • The largest Matinas BioPharma buyer in Q4 2019 was BlackRock, an estimated $1.61M added.
  • The largest Matinas BioPharma seller in Q4 2019 was Granite Point Capital Management, an estimated $946K sold.

Based on aggregated 13F filings for Q4 2019.